You are viewing: India Endoscopic Submucosal Dissection/ESD Market analysis

The India Endoscopic Submucosal Dissection/ESD Market was valued at $7 Million in 2025 and projected to reach to $11.2 Million by 2030, representing a compound annual growth rate of 9.8%. India's ESD market is poised for sustained expansion driven by increasing cancer awareness, improving healthcare infrastructure, and growing physician expertise in minimally invasive techniques.

India Endoscopic Submucosal Dissection/ESD Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

India Endoscopic Submucosal Dissection/ESD Market Trends and Insights

  • This 9.8% compound annual growth rate reflects India's increasing adoption of minimally invasive endoscopic procedures for early-stage gastrointestinal malignancies.
  • India's growing prevalence of esophageal and gastric cancers, coupled with rising healthcare expenditure and improved access to advanced endoscopic technologies, is driving market expansion across metropolitan and tier-2 cities. The Indian ESD market is supported by expanding hospital infrastructure, growing physician training programs, and rising patient awareness of tissue-preserving treatment options.
  • India's healthcare sector modernization and government initiatives to enhance cancer care capabilities are accelerating the adoption of ESD techniques among gastroenterologists and surgical endoscopists.
  • Between 2025 and 2030, India is expected to see increased investment in endoscopic equipment and consumables, positioning the country as a key growth market within the Asia Pacific region for minimally invasive GI interventions..

Key Market Statistics

  • CAGR (2025-2030) 9.8% CAGR
  • Market Size, 2025 ~USD 7 Million
  • Forecast, 2030 ~USD 11.2 Million
  • Country India

India Endoscopic Submucosal Dissection/ESD Market Overview

Market Valuation & Growth :

India's ESD market is valued at USD 7.0 million in 2025, with a robust 9.8% CAGR projected through 2030, reaching USD 11.2 million. This growth rate outpaces the global average of 8.4%, indicating accelerating adoption in the Indian healthcare sector.

Rising Cancer Prevalence :

India faces a significant burden of esophageal and gastric cancers, driving demand for early-stage intervention techniques. ESD's minimally invasive approach addresses the need for effective treatment options in a population with high gastrointestinal malignancy rates.

Healthcare Infrastructure Expansion :

Tier-1 and emerging Tier-2 cities in India are increasingly investing in advanced endoscopic equipment and training. Government initiatives and private hospital networks are expanding access to ESD procedures beyond metropolitan centers.

Procedural Adoption Momentum :

Indian gastroenterologists and surgical centers are rapidly adopting ESD over traditional surgical resection due to reduced morbidity, shorter hospital stays, and improved patient outcomes. Training programs and international collaborations are accelerating skill development.

India Endoscopic Submucosal Dissection/ESD Market Dynamics

  • The rising middle-class population with better healthcare access and insurance coverage is fueling demand for advanced endoscopic procedures.
  • Government healthcare initiatives and private sector investments in tertiary care facilities are expanding ESD availability beyond major metropolitan areas.
  • India's young population and improving diagnostic capabilities are expected to drive early detection rates, further boosting ESD adoption through 2030..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • India's ESD market is valued at USD 7.0 million in 2025 and is forecast to reach USD 11.2 million by 2030, representing a 9.8% CAGR.
    • Rising incidence of early-stage gastrointestinal cancers in India is driving demand for tissue-preserving endoscopic procedures.
    • India's expanding healthcare infrastructure and physician training initiatives are accelerating ESD adoption across major metropolitan and emerging healthcare centers.
    • Government healthcare modernization programs and increased cancer care investment position India as a high-growth market for minimally invasive endoscopic technologies.

    Endoscopic Submucosal Dissection/ESD Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment KNIVES (Product)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.4% from 2025 to 2030
    Largest Segment GASTROSCOPES & COLONOSCOPES (Product)
    Market Size Base Year (Billions) ~USD 0.5 (2025)
    Revenue Forecast (Billions) ~USD 0.75 (2030)
    Segments Covered Product, Indication, End User

    India Endoscopic Submucosal Dissection/ESD Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Gastroscopes & Colonoscopes
    • Grasp/Clips
    • Graspers/Clips
    • Injection Agents
    • Knives
    • Other Products
    • Tissue Retractors

    By Indication

    • Colon Cancer
    • Esophageal Cancer
    • Stomach Cancer

    By End User

    • Ambulatory Surgical Centers
    • Hospitals
    • Other End Users
    • Specialty Clinics

    INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    AMBULATORY SURGICAL CENTERS2.212.382.642.883.163.483.814.189.6
    HOSPITALS7.718.359.310.1711.2312.3913.6315.0210.1
    OTHER END USERS0.390.420.460.490.530.580.630.688.3
    SPECIALTY CLINICS2.552.743.043.33.623.964.334.749.3
    TOTAL12.8613.8915.4316.8318.5420.4122.424.639.8

    Target Audience

    • Medical Device Manufacturers : Manufacturers of endoscopic equipment, ESD instruments, and accessories need India-specific market data to develop localized product strategies, identify distribution partnerships, and plan manufacturing or assembly operations in India.
    • Healthcare Providers & Hospital Networks : Hospital administrators and gastroenterology departments require market insights to justify ESD program investments, benchmark procedural volumes against regional peers, and plan training initiatives for clinical staff.
    • Private Equity & Investment Firms : Investors evaluating healthcare opportunities in India need detailed market analysis to assess growth potential, identify acquisition targets in the endoscopy space, and evaluate returns on healthcare infrastructure investments.
    • Consulting & Strategy Firms : Management consultants advising healthcare clients require India-specific ESD market data to support strategic planning, market sizing, competitive analysis, and go-to-market recommendations for their healthcare sector clients.
    • Government & Policy Bodies : Healthcare policymakers and government agencies need market intelligence to inform healthcare infrastructure planning, medical technology procurement decisions, and policy frameworks supporting adoption of advanced endoscopic procedures.

    Key Companies in the India Endoscopic Submucosal Dissection/ESD Market

    CompanyHQOwnershipStrongest segments
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions,Urology,Respiratory,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    FUJIFILM HOLDINGS CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative medicine, cosmetics/supplements),Electronics (display/touch, semiconductor and image sensor materials, storage/archiving, industrial equipment, fine chemicals),Business Innovation (office equipment, document solutions, graphic communications, inkjet heads),
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, peripheral interventions, oncology),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health,
    SUMITOMO BAKELITE CO., LTD.JapanPublic CompanySemiconductor encapsulation and substrate materials,Phenolic molding compounds and industrial resins,Copper-clad laminates (phenolic and epoxy),
    CREO MEDICAL GROUP PLCUnited KingdomPublic CompanyCROMA platform and capital equipment,Speedboat Inject and multimodal endoscopic instruments,MicroBlate Fine and MicroBlate Flex ablation devices,
    HOYA CORPORATIONJapanPublic CompanyEyeglasses and ophthalmic lenses,Contact lenses and Eyecity retail,Intraocular lenses and surgical ophthalmology,
    CONMED CORPORATIONUnited StatesPublic CompanyOrthopedic & Sports Medicine (BioBrace, Y-Knot, TruShot, Hall power tools),General Surgery (AirSeal insufflation, Buffalo Filter smoke, endomechanical),Endoscopic Technologies (GI therapeutic and diagnostic),
    STERISIrelandPublic CompanyHealthcare sterilization and washer-disinfectors,Endoscope reprocessing systems and consumables,Operating room equipment and integration,

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates as a diversified manufacturer with significant operations in medical devices and imaging technology.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees. It is a global leader in medical technology, services, and solutions.

    FUJIFILM HOLDINGS CORPORATION

    Fujifilm Holdings Corporation is a Japanese public company established in 1934 with 73,526 employees. The company operates across imaging, information, and document solutions, as well as healthcare and materials sectors.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. It specializes in the development and manufacture of medical devices and technologies.

    SUMITOMO BAKELITE CO., LTD.

    Sumitomo Bakelite Co., Ltd. is a Japanese public company founded in 1932 with 7,524 employees. The company manufactures advanced materials and components for various industrial applications.

    CREO MEDICAL GROUP PLC

    Creo Medical Group PLC is a United Kingdom-based public company founded in 2003 with 104 employees. The company develops and commercializes medical devices and technologies.

    HOYA CORPORATION

    Hoya Corporation is a Japanese public company established in 1941 with 37,752 employees. The company manufactures optical products, medical devices, and precision equipment.

    CONMED CORPORATION

    CONMED Corporation is a United States-based public company founded in 1970 with 3,900 employees. The company designs, manufactures, and sells medical devices and equipment for surgical and patient monitoring applications.

    STERIS

    STERIS is a public company headquartered in Ireland, founded in 1985. The company provides sterilization and contamination control products and services for healthcare and industrial markets.

    Reasons to Buy this Report

    • Market Entry Strategy : Comprehensive India-specific data enables medical device manufacturers and healthcare providers to develop targeted market entry strategies, identify key growth corridors, and allocate resources effectively across metropolitan and emerging markets.
    • Competitive Positioning : Understand India's unique competitive landscape, local player strategies, and pricing dynamics. Benchmark your offerings against regional competitors and identify white-space opportunities in underserved segments and geographies.
    • Investment Decision Support : Validate investment decisions with India-specific growth projections, market size data, and CAGR analysis. Support board presentations and funding proposals with credible market research tailored to the Indian healthcare ecosystem.
    • Regulatory & Reimbursement Insights : Navigate India's healthcare regulatory environment, insurance coverage patterns, and government healthcare schemes. Understand reimbursement rates and policy drivers affecting ESD procedure adoption and market expansion.
    • Demand Forecasting : Leverage India-specific market forecasts through 2030 to optimize supply chain planning, inventory management, and capacity building. Align production and distribution strategies with projected demand growth in key Indian markets.

    Frequently asked questions

    What is the current market size of ESD in India?

    India's ESD market was valued at USD 7.0 million in 2025 and is projected to grow to USD 11.2 million by 2030.

    What is the expected growth rate for India's ESD market?

    India's ESD market is expected to grow at a compound annual growth rate (CAGR) of 9.8% from 2025 to 2030.

    What factors are driving ESD market growth in India?

    Key growth drivers in India include rising prevalence of gastrointestinal cancers, expanding hospital infrastructure, physician training programs, and government healthcare modernization initiatives.

    Which regions in India are leading ESD adoption?

    Metropolitan cities and tier-2 healthcare centers in India are leading ESD adoption, supported by improved access to advanced endoscopic technologies and trained specialists.

    How does India's ESD market compare to other Asia Pacific countries?

    India represents a high-growth segment within Asia Pacific, with a 9.8% CAGR driven by large patient population, rising cancer incidence, and healthcare sector expansion.

    RESEARCH METHODOLOGY

    The study focused on estimating the current size of the endoscopic submucosal dissection (ESD) market. We conducted thorough secondary research to gather information about the market. The next step involved validating our findings, assumptions, and estimates through primary research by consulting industry experts throughout the value chain. We used various approaches, including top-down and bottom-up methods, to calculate the total market size. Subsequently, we applied market breakdown and data triangulation techniques to estimate the sizes of different segments and subsegments within the ESD market.

    Secondary Research

    This research study heavily utilized secondary sources, including directories and databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and company documents. The purpose of the secondary research was to identify and gather information for a comprehensive, technical, market-oriented, and commercial analysis of the endoscopic submucosal dissection (ESD) market. It also aimed to collect vital information about leading industry players, market classification, and segmentation according to industry trends, down to the most granular levels, as well as geographic markets and key developments related to the market. Additionally, a database of key industry leaders was created based on the findings from the secondary research.

    Primary Research

    During the primary research process, a variety of supply-side and demand-side sources were interviewed to gather both qualitative and quantitative information for this report. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, engineers, and other key executives from various companies and organizations operating in the ESD market. On the demand side, primary sources encompassed hospitals, clinics, researchers, lab technicians, purchasing managers, and stakeholders from corporate and government bodies.

    Breakdown of Primary Interviews

    Endoscopic Submucosal Dissection Market

    Note 1: C-level executives include CEOs, COOs, and CTOs.

    Note 2: Others include sales, marketing, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ESD market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Endoscopic Submucosal Dissection Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ESD. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    Endoscopic submucosal dissection (ESD) is an advanced therapeutic endoscopy technique for superficial gastrointestinal neoplasms. In endoscopic submucosal dissection, the equipment includes different types of knives, forceps, snares, and a few other products that support the procedure, as well as accessories used to ease the handling of instruments during surgeries.

    Stakeholders

    • Manufacturers of endoscopes and related devices
    • Suppliers and distributors of endoscopy devices
    • Hospitals, diagnostic centers, and medical colleges
    • Independent surgeons and private offices of physicians
    • Ambulatory surgery centers (ASCs)
    • Teaching hospitals and academic medical centers
    • Government bodies/municipal corporations
    • Business research and consulting service providers
    • Venture capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the endoscopic submucosal dissection market by product, indication, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall endoscopic submucosal dissection market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the endoscopic submucosal dissection market in six regions: North America (US and Canada), Europe (Germany, the UK, France, Spain, Italy, and the Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), the Middle East & Africa, and the GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full Endoscopic Submucosal Dissection/ESD Market Report

    Full forecast, segment splits, and company analysis for all Endoscopic Submucosal Dissection/ESD Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status